BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:39 pm
Sale		 2024-09-30 13G Ovid Therapeutics Inc.
OVID		 BIOTECHNOLOGY VALUE FUND L P 3,853,818
5.400%		 -2,997,233decrease
(-43.75%)		 Filing
2023-02-13
6:22 pm
Purchase		 2022-12-31 13G Ovid Therapeutics Inc.
OVID		 BIOTECHNOLOGY VALUE FUND L P 6,851,051
9.700%		 220,000increase
(+3.32%)		 Filing
2021-04-15
4:11 pm
Purchase		 2021-04-13 13G Ovid Therapeutics Inc.
OVID		 BIOTECHNOLOGY VALUE FUND L P 6,631,051
10.100%		 2,109,000increase
(+46.64%)		 Filing
2021-02-12
4:18 pm
Sale		 2020-12-31 13G Ovid Therapeutics Inc.
OVID		 BIOTECHNOLOGY VALUE FUND L P 4,522,051
6.900%		 -733,250decrease
(-13.95%)		 Filing